診断精度研究のバイアスリスク評価ツールQUADAS－2：a Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies 2 の活用

By 小島原典子, 森實敏夫, 中山健夫, 福岡敏雄, 河合富士美, 佐藤康仁, 吉田雅博, 山口直人. 2014

2,238 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/97389f9679a5432df8f5c1e19bc306d8e683bdf5

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. L. Mokkink
2. C. Prinsen
3. C. Terwee
4. Andrea C. Tricco
5. HC de Vet
6. Lex M. Bouter
7. M. Peters
8. D.walaa badawy

Citations in the corpus

• The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta‐analysis, and clinical practice guideline: a systematic review (2015, methodology): “The Cochrane Collaboration takes QUADAS as it is a standard tool for making CSR and set QUADAS in the Review Manager (RevMan) 5.0 software (http://srdta.cochrane.org/handbook-dta-reviews).”
• Evidence‐Based Assessment as an Integrative Model for Applying Psychological Science to Guide the Voyage of Treatment (2017, background): “…Board Working Group on Journal Article Reporting Standards, 2008; Bossuyt et al., 2003) and critical appraisal tools (Straus et al., 2011; Whiting et al., 2011) all warn about potential design defects, and meta-analyses show these can have large biasing effects (Youngstrom, Genzlinger,…”
• A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models. (2019, methodology): “The list of extraction items was based on the CHARMS checklist and the QUADAS risk of bias tool and refined after extensive discussion among the authors [9,22].”
• COSMIN Risk of Bias checklist for systematic reviews of Patient-Reported Outcome Measures (2017, methodology): “The COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) checklist is a tool developed to assess the methodological quality of single studies on measurement properties of PROMs [4, 5]; likewise, the Quality Assessment of Diagnostic Accuracy Studies (QUADAS) tool is ”
• PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation (2018, background): “It 299 consists of 10 items that reached agreement in rounds 1 and 2 (1,3,5,6,8,9,17,25-27), 300 along with the 10 items that were agreed upon in round 3 (2,4, 7,10,11,14,18,20,21,24).”
• Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis (2018, methodology): “) independently assessed study quality by a modified checklist based upon the Quality Assessment Tool for Diagnostic Accuracy (QUADAS2) guidelines with discrepancies resolved by consensus.(13)”
• Developments, application, and performance of artificial intelligence in dentistry – A systematic review (2020, methodology): “A critical assessment was carried out for all the articles by following QUADAS-2 (Quality Assessment and Diagnostic Accuracy Tool) guidelines, a tool for quality assessment of the studies on diagnostic accuracy.(10) 3 more articles were excluded due to disagreement from the authors.”
• The Clinician-Administered PTSD Scale for DSM–5 (CAPS-5): Development and Initial Psychometric Evaluation in Military Veterans (2017, methodology): “This study followed the second version of the Quality Assessment of Diagnostic Accuracy Studies guidelines (QUADAS-2; Whiting et al., 2011), which minimizes the influence of various sources of bias that can affect diagnostic utility studies (see Bovin et al., 2016).”
• Circulating MicroRNAs as a Novel Class of Diagnostic Biomarkers in Gastrointestinal Tumors Detection: A Meta-Analysis Based on 42 Articles (2014, methodology): “Quality assessment The qualities of included studies were scored independently by two reviewers using the revised Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) criteria [29].”
• Risk‐of‐bias VISualization (robvis): An R package and Shiny web app for visualizing risk‐of‐bias assessments (2020, methodology): “At the time of writing, the tool includes templates for three major tools: the Cochrane RoB 2 tool for assessing randomized trials,(3) the ROBINS-I tool for assessing non-randomized studies of interventions,(4) and the QUADAS-2 tool for assessing diagnostic accuracy studies.(5) These templates autom”